Assignee profile:

Vitae Pharmaceuticals, LLC

City:

MADISON, New Jersey

Country:

United States

Published Applications:

14

Last publication date:

2024-04-18

Patent Grants:

13

Last grant date:

2022-12-27

Top Inventors for applications by Vitae Pharmaceuticals, LLC

These are the the leading inventors for applications assigned to Vitae Pharmaceuticals, LLC:

Recent patent applications by Vitae Pharmaceuticals, LLC

Vitae Pharmaceuticals, LLC based in MADISON, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-04-18
US20240124447A1
Chemistry; metallurgy

INHIBITORS OF THE MENIN-MLL INTERACTION

#2 | 2021-08-05 ✅ Patent 11,535,614 granted on 2022-12-27
US20210238174A1
Chemistry; metallurgy

Dihydropyrrolopyridine inhibitors of ROR-gamma

#3 | 2021-06-17 ✅ Patent 11,739,085 granted on 2023-08-29
US20210179611A1
Chemistry; metallurgy

Inhibitors of the menin-MLL interaction

#4 | 2021-02-25 ✅ Patent 11,479,557 granted on 2022-10-25
US20210053974A1
Chemistry; metallurgy

Inhibitors of the menin-MLL interaction

#5 | 2020-06-04 ✅ Patent 10,807,980 granted on 2020-10-20
US20200172535A1
Chemistry; metallurgy

Dihydropyrrolopyridine inhibitors of ROR-gamma

#6 | 2020-05-28 ✅ Patent 11,186,573 granted on 2021-11-30
US20200165245A1
Chemistry; metallurgy

Inhibitors of ROR gamma

#7 | 2020-03-12 ✅ Patent 11,001,583 granted on 2021-05-11
US20200079767A1
Chemistry; metallurgy

Dihydropyrrolopyridine inhibitors of ROR-gamma

#8 | 2020-02-27 ✅ Patent 10,829,448 granted on 2020-11-10
US20200062707A1
Chemistry; metallurgy

Substituted benzoimidazoles as modulators of ROR-γ

#9 | 2019-11-21 ✅ Patent 10,829,481 granted on 2020-11-10
US20190352286A1
Chemistry; metallurgy

Benzimidazole derivatives as modulators of ROR-gamma

#10 | 2019-10-24 ✅ Patent 11,008,340 granted on 2021-05-18
US20190322687A1
Chemistry; metallurgy

Modulators of ROR-gamma

#11 | 2019-07-04 ✅ Patent 10,899,758 granted on 2021-01-26
US20190202830A1
Chemistry; metallurgy

Inhibitors of the menin-MLL interaction

#12 | 2019-05-16 ✅ Patent 10,683,302 granted on 2020-06-16
US20190144459A1
Chemistry; metallurgy

Inhibitors of the menin-MLL interaction

#13 | 2018-12-27 ✅ Patent 10,399,976 granted on 2019-09-03
US20180370968A1
Chemistry; metallurgy

Dihydropyrrolopyridine inhibitors of ROR-gamma

#14 | 2018-08-09 ✅ Patent 10,301,261 granted on 2019-05-28
US20180222860A1
Chemistry; metallurgy

Substituted indoles as modulators of ROR-gamma

Also check out VITAE PHARMACEUTICALS, LLC's (Madison, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

171281 ⎘